3349
COSMOS Pharmaceutical Corporation
株式会社コスモス薬品COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, and food products in Japan. The company offers general medicines, energy drinks, oral and nursing care products, vitamins, health foods, diet foods, and prescriptions; and hair care and bath products. It also provides baby products, detergents, insect repellents, air fresheners, bath and toilet products, cooking supplies, gardening supplies, household and cleaning supplies, and clothing; processed foods, daily necessities, seasonings, confectionery, beverages, and alcohol; and tobacco and other products. In addition, the company engages in the maintenance and management of buildings and commercial facilities, traffic control, and security contracting activities. It sells its products through retail stores and online. COSMOS Pharmaceutical Corporation was incorporated in 1983 and is headquartered in Fukuoka City, Japan.
Price
¥6,012
Market Cap
¥476.5B
Ent. Value
¥462.3B
Net Cash
¥14.2B
Shares Out.
79.3M
P / E
15.4×
EV / EBIT
11.4×
P / Book
1.85×
P / NCAV
N/M
Div. Yield
1.16%
Financials
| Metric |
FY 2025
EDINET ↗ |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
|---|---|---|---|---|---|
| Net Sales | ¥1,011.4B | ¥965.0B | ¥827.7B | ¥755.4B | ¥726.4B |
| Cost of Sales | ¥798.1B | ¥776.7B | ¥659.0B | ¥604.0B | ¥581.3B |
| Gross Profit | ¥213.3B | ¥188.3B | ¥168.7B | ¥151.4B | ¥145.1B |
| SG&A | ¥172.9B | ¥156.8B | ¥138.6B | ¥121.7B | ¥112.0B |
| Operating Income | ¥40.4B | ¥31.5B | ¥30.1B | ¥29.8B | ¥33.1B |
| Non-Operating Income | ¥3.7B | ¥3.6B | ¥3.7B | ¥3.7B | ¥3.4B |
| Interest Income | ¥48M | ¥44M | ¥47M | ¥52M | ¥57M |
| Non-Operating Expenses | ¥988M | ¥839M | ¥719M | ¥629M | ¥736M |
| Interest Expense | ¥254M | ¥99M | ¥51M | ¥52M | ¥60M |
| Ordinary Income | ¥43.2B | ¥34.3B | ¥33.1B | ¥32.9B | ¥35.8B |
| Pre-tax Income | ¥42.4B | ¥33.7B | ¥32.8B | ¥33.0B | ¥38.6B |
| Income Taxes | ¥11.4B | ¥9.3B | ¥9.0B | ¥9.9B | ¥11.4B |
| Current Tax | ¥11.8B | ¥9.5B | ¥9.3B | ¥10.0B | ¥11.7B |
| Deferred Tax | ¥-451M | ¥-219M | ¥-318M | ¥-81M | ¥-242M |
| Net Income (owners) | ¥31.0B | ¥24.5B | ¥23.8B | ¥23.2B | ¥27.2B |
| Comprehensive Income | ¥31.0B | ¥24.5B | ¥23.8B | ¥23.2B | ¥27.2B |
| EBITDA | ¥62.6B | ¥51.4B | ¥47.5B | ¥44.9B | ¥46.9B |
| EPS | ¥390.86 | ¥617.22 | ¥600.96 | ¥584.76 | ¥685.80 |
| Shares Outstanding | 79.3M | 39.6M | 39.6M | 39.6M | 39.6M |
| Shares Issued (total) | 80.0M | 40.0M | 40.0M | 40.0M | 40.0M |
| Treasury Shares | 0.7M | 0.4M | 0.4M | 0.4M | 0.4M |